Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Operating Expenses | 3,662 | 5,940 | 3,709 | 3,294 | 2,796 |
Operating Income | -3,662 | -5,940 | -3,709 | -3,294 | -2,796 |
Other Income | 38 | 36 | 72 | 54 | 8 |
Pre-tax Income | -3,624 | -5,904 | -3,637 | -3,240 | -2,788 |
Net Income Continuous | -3,624 | -5,904 | -3,637 | -3,240 | -2,788 |
Net Income | $-3,624 | $-5,904 | $-3,637 | $-3,240 | $-2,788 |
EPS Basic Total Ops | -10.08 | -17.60 | 26.91 | -14.20 | -36.40 |
EPS Basic Continuous Ops | -10.08 | -17.57 | 27.07 | -14.29 | -36.44 |
EPS Diluted Total Ops | -10.08 | -17.60 | 26.91 | -14.20 | -36.40 |
EPS Diluted Continuous Ops | -10.08 | -17.57 | 27.07 | -14.29 | -36.44 |
EBITDA(a) | $-3,597 | $-5,875 | $-3,647 | $-3,228 | $-2,728 |